Atomo News
Get the app
Get the latest Science News and Discoveries
Ibrutinib with rituximab in previously untreated CLL: indication of added benefit over FCR
None
Get the Android app
Or read this on Eureka Alert
Read more on:
Ibrutinib
FCR
« New Method for Measuring Spatial Dependencies Turns Less Data Into More
COVID-19 news from Annals of Internal Medicine »